Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2024-10-25 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations of compliance with listing rules. The content is focused on reporting share repurchase activity and changes in share capital rather than announcing a new report or providing financial results. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is POS with high confidence.
2024-10-25 English
List of Directors and their Role and Function
Governance Information Classification · 95% confidence The document lists the members of the board of directors and their roles, as well as the membership of board committees such as the Audit Committee, Remuneration Committee, and Nomination Committee. There is no financial data, no mention of a report or meeting, and no indication of changes in management or voting results. The content focuses on governance structure and board composition, which aligns with Governance Information filings. The document length is short and it is not an announcement of a report publication or a certification. Therefore, the most appropriate classification is Governance Information (CGR).
2024-10-21 English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from Ocumension Therapeutics regarding the resignation of a non-executive director, Ms. Yumeng Wang. It discusses the immediate effect of the resignation, the impact on board gender diversity compliance under the Stock Exchange Listing Rules, and the company's intention to appoint a suitable female candidate. There is no financial data, no mention of a report or financial results, and the content focuses solely on board management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of a management change, not a report or other filing type.
2024-10-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations about compliance with listing rules and legal requirements related to share repurchases. The content is regulatory in nature, focused on disclosure of share transactions rather than financial results or management commentary. It is not an annual or interim report, earnings release, or management discussion. It is a formal regulatory disclosure about share repurchases and treasury shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length and detail confirm it is the report itself, not just an announcement of a report publication.
2024-10-17 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and details share repurchase transactions, issuance of new shares, and confirmations of compliance with listing rules. The content is focused on share capital changes and repurchase activities, with detailed tables of share numbers, prices, and dates. This matches the description of a 'Transaction in Own Shares' filing, which reports on the company's buying back or selling its own shares. The document is substantive and not merely an announcement or certification, and it does not fit other categories like capital financing updates or regulatory filings. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-10-16 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 16, 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on October 16, 2024. It details the voting outcomes on several ordinary resolutions related to transaction documents, share issuance mandates, and annual caps. The document does not contain full financial statements or detailed financial analysis but focuses on the official voting results of shareholder resolutions. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting (AGM or EGM). The document length is about 5974 characters, which is sufficient for a detailed voting result announcement but does not constitute a full report like an Annual Report or Interim Report. Therefore, the correct classification is DVA with high confidence.
2024-10-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.